Last reviewed · How we verify

NCT06635434

An English/Spanish Mobile Augmented Reality Pain Assessment App for Hispanic/Latino Pediatric Cancer Patients

Active, enrolled EARLY_PHASE1 Last updated 26 October 2024
What this trial tests

EARLY_PHASE1 trial testing AR Pain assessment in Pain in 16 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
5 February 2023
Primary endpoint
31 October 2024
30 November 2024

Quick facts

Lead sponsorALTality, Inc.
PhaseEARLY_PHASE1
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposedevice feasibility
Enrollment16
Start date5 February 2023
Primary completion31 October 2024
Estimated completion30 November 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

ALTality, Inc.

Who can join

Adults 7 to 17, any sex, with Pain or Pediatric Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this SBIR, ALTality, Inc. ("SpellBound") will assess the feasibility of a dual English/Spanish language augmented reality(AR)-enabled tool for assessing inpatient postoperative pain/nausea/vomiting in Hispanic/Latino children and adolescents with cancer in collaboration with bilingual Spanish-speaking anesthesiologists at the MD Anderson Cancer Center. If successful, the AR app will be an immediately implementable and commercially viable method of providing Hispanic/Latino pediatric cancer patients with limited English proficiency an adjunctive tool to overcome infrastructural barriers to receiving translation services in acute care settings that put them at higher risk of under and/or overtreatment of pain by prescription opioids and future prescription opioid dependency and misuse, at no cost to them or their families.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pain

Currently open trials in the same condition.

Other ALTality, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06635434.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing